We are live on !
Find out more
CA
Crewe Advisors Portfolio holdings
AUM
$1.38B
Turnover
19.9%
1-Year Est. Return
41.76%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
–
AUM
$712M
AUM Growth
+$26.8M
(+3.9%)
Cap. Flow
-$6.23M
Cap. Flow % of AUM
Cap. Flow %
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
57.17%
Holding
1,032
New
221
Increased
124
Reduced
277
Closed
164
Avg Time Held
1.7
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$9.05M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.69M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$1.53M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.15M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$993K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$3.14M |
| 2 |
The Ensign Group
ENSG
|
+$2.36M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$2.09M |
| 4 |
Amazon
AMZN
|
+$1.15M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$772K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.76% |
| 2 | Healthcare | 18.8% |
| 3 | Financials | 6.68% |
| 4 | Technology | 5.76% |
| 5 | Consumer Discretionary | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
DELISTED
The Aaron's Company Inc
AAN
| – | – |
-699
| Closed | -$6.75K | – |
|
1027
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-61
| Closed | -$2.39K | – |
|
|
MRTX
1028
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-33
| Closed | -$1.23K | – |
|
|
ISEE
1029
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-452
| Closed | -$11K | – |
|
|
XM
1030
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| – | – |
-16,635
| Closed | -$297K | – |
|
|
FRC
1031
DELISTED
First Republic Bank
FRC
| – | – |
-150
| Closed | -$2.1K | – |
|
|
HZNP
1032
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-123
| Closed | -$13.4K | – |
|
Similar funds
DPI
AIM
TCA
DP
RG
PIMJS
TAM
XF
Crewe Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Crewe Advisors held 1,032 positions worth $712M, up 3.9% from $686M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Crewe Advisors's Q2 2023 filing shows 221 new, 124 increased, 277 reduced and 164 closed positions. Its largest new stake was Bank of Montreal: 315 shares worth $28.4K. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $3.14M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Healthcare and Financials.
- Crewe Advisors's largest Q2 2023 buy was Bank of Montreal: 315 shares worth $28.4K.
- Crewe Advisors added most to Vanguard Total Bond Market in Q2 2023, an estimated $9.05M increase.
- Crewe Advisors's biggest Q2 2023 reduction was The Ensign Group, cutting an estimated $2.36M.
- Crewe Advisors fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2023, selling an estimated $3.14M.
- Crewe Advisors's ten largest holdings make up 57% of its $712M portfolio in Q2 2023.
- Crewe Advisors opened 221 new positions and closed 164 in Q2 2023.
- Crewe Advisors's portfolio value rose 3.9% quarter-over-quarter to $712M.
Based on Crewe Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.